Amgen third quarter sales rise 8%, led by cholesterol, cancer drugs
IN
Investing.comBy Reuters
EXECUTIVE SUMMARY
Amgen third quarter sales rise 8%, led by cholesterol, cancer drugs....
Key Takeaways
- Amgen third quarter sales rise 8%, led by cholesterol, cancer drugs.
Read Complete Original Article
Published originally on Investing.com





